{
  "parsed_data": {
    "protein_targets": [
      {
        "name": "EGFR",
        "full_name": "Epidermal Growth Factor Receptor",
        "organism": null,
        "mutations": [
          {
            "original_residue": "T",
            "position": 790,
            "mutated_residue": "M"
          }
        ],
        "binding_sites": [
          "ATP binding site"
        ]
      }
    ],
    "molecule_properties": {
      "blood_brain_barrier_permeability": null,
      "lipinski_rule_of_five": true,
      "toxicity_requirements": null,
      "solubility_requirements": null,
      "other_requirements": "oral bioavailability"
    },
    "confidence": 0.8,
    "clarification_questions": [
      "What is the desired level of selectivity over wild-type EGFR?",
      "What are the specific requirements for oral bioavailability?",
      "What are the specific drug-like properties that must be followed?"
    ]
  },
  "sequences": {
    "EGFR": {
      "accession": "Q9WTS1",
      "original_sequence": "MRPSGTARTKLLLLLAALCAAGGALEEK",
      "sequence": "MRPSGTARTKLLLLLAALCAAGGALEEK",
      "length": 28,
      "mutations": [
        {
          "original_residue": "T",
          "position": 790,
          "mutated_residue": "M"
        }
      ],
      "organism": "Rattus norvegicus",
      "protein_name": "EGFR",
      "gene_name": "EGFR"
    }
  },
  "config_files": {
    "EGFR_fasta": "/scratch/rajagopalmohanraj.n/F.A.D.E/data/inputs/sequences/EGFR.fasta",
    "EGFR_alphafold_config": "/scratch/rajagopalmohanraj.n/F.A.D.E/data/inputs/configs/EGFR_alphafold.json",
    "EGFR_alphafold_job": "/scratch/rajagopalmohanraj.n/F.A.D.E/data/inputs/job_scripts/EGFR_alphafold.sh",
    "parsed_query": "/scratch/rajagopalmohanraj.n/F.A.D.E/data/inputs/configs/parsed_query.json"
  }
}